Biden Administration Unveils Plan to Cut Prescription-Drug Prices - WSJ

To spur new drug innovations, the administration would launch an agency at the National Institutes of Health to drive biomedical breakthroughs. Mr. Biden requested $6.5 billion for three years in his fiscal 2022 budget for the NIH, whose focus would be to “foster medical innovations,” including for diseases such as cancer, diabetes and Alzheimers.

Duplicative effort far more efficiently performed by the private market. Just another waste of taxpayer dollars on a project outside of the core competency of government.

Also kind of funny that Alzheimer’s is specifically named when the government is trashing the first serious new therapy in years.